This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brodsky, S. J. Articles by Klein, M. D. Search for Related Content PubMed PubMed Citation Articles by Brodsky, S. J. Articles by Klein, M. D.

Circulation, Vol 66, 569-574, Copyright © 1982 by American Heart Association

ARTICLES

Treatment of stable angina of effort with verapamil: a double-blind, placebo-controlled randomized crossover study

SJ Brodsky, SS Cutler, DA Weiner, CH McCabe, TJ Ryan and MD Klein

The effects of verapamil were assessed in 26 patients with stable exertional angina pectoris in a double-blind, placebo-controlled, randomized crossover protocol using serial treadmill tests. Verapamil, 480 mg/day, reduced anginal frequency from 5.6 +/- 7.3 to 2.2 +/- 3.9 attacks per week (p less than 0.001) and nitroglycerin consumption from 3.4 +/- 4.9 to 1.2 +/- 2.5 tablets per week (p less than 0.05) compared with placebo. Treadmill time increased from 6.4 +/- 2.1 minutes during the placebo phase to 7.5 +/- 1.8 minutes during the verapamil phase (p less than 0.001). Verapamil's beneficial effect appeared to be related, in part, to a 10% reduction of the rate-pressure product at rest (p less than 0.05) and a 12% reduction during submaximal exercise (p less than 0.001). Verapamil also caused less marked ST-segment depressions at peak exercise (p less than 0.05) at a similar rate-pressure product, suggesting a favorable redistribution of coronary blood flow to the ischemic zone. Side effects from verapamil were minimal, consisting mainly of constipation (six patients). Verapamil appears to be a safe and effective drug for treating angina of effort.

This article has been cited by other articles:

				W. H. Frishman and S. Charlap Verapamil in Treatment of Chronic Stable Angina Arch Intern Med, July 1, 1983; 143(7): 1407 - 1415. [Abstract] [PDF]